Orestis L Katsamenis

Dr. Orestis L Katsamenis

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
HKHyun-Kyoung Koo
Hyun-Kyoung Koo
DVDragoş M Vasilescu
Dragoş M Vasilescu
SBSteven Booth
Steven Booth
AHAileen Hsieh
Aileen Hsieh
OKOrestis L Katsamenis
Orestis L Katsamenis
THTillie-Louise Hackett
Tillie-Louise Hackett

1 July 2018 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
CGChristos I. Gioumouxouzis
Christos I. Gioumouxouzis
ABApostolos Baklavaridis
Apostolos Baklavaridis
OKOrestis L Katsamenis
Orestis L Katsamenis
CMCatherine K. Markopoulou
Catherine K. Markopoulou
NBNikolaos Bouropoulos
Nikolaos Bouropoulos
DFDimitrios Fatouros
Dimitrios Fatouros

13 February 2013 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
JKJ. Knychala
J. Knychala
NBN. Bouropoulos
N. Bouropoulos
CCC. J. Catt
C. J. Catt
OKOrestis L Katsamenis
Orestis L Katsamenis
CPC. P. Please
C. P. Please
BSB. G. Sengers
B. G. Sengers

1 August 2019 in The American Journal of Pathology
Verified
Journal Article
Open access
OKOrestis L Katsamenis
Orestis L Katsamenis
MOMichael Olding
Michael Olding
JWJane A. Warner
Jane A. Warner
DCDavid S. Chatelet
David S. Chatelet
MJMark Jones
Mark Jones
PSPhilipp Schneider
Philipp Schneider
Historically, micro-computed tomography (μCT) has been considered unsuitable for histologic analysis of unstained formalin-fixed, paraffin-embedded soft tissue biopsy specimens because of a lack of image contrast between the tissue and the paraffin. However, we recently demonstrated that μCT can successfully resolve microstructural detail in routinely prepared tissue specimens. Herein, we illustrate how μCT imaging of standard formalin-fixed, paraffin-embedded biopsy specimens can be seamlessly integrated into conventional histology workflows, enabling nondestructive three-dimensional (3D) X-ray histology, the use and benefits of which we showcase for the exemplar of human lung biopsy specimens. This technology advancement was achieved through manufacturing a first-of-kind μCT scanner for X-ray histology and developing optimized imaging protocols, which do not require any additional sample preparation. 3D X-ray histology allows for nondestructive 3D imaging of tissue microstructure, resolving structural connectivity and heterogeneity of complex tissue networks, such as the vascular network or the respiratory tract. We also demonstrate that 3D X-ray histology can yield consistent and reproducible image quality, enabling quantitative assessment of a tissue's 3D microstructures, which is inaccessible to conventional two-dimensional histology. Being nondestructive, the technique does not interfere with histology workflows, permitting subsequent tissue characterization by means of conventional light microscopy-based histology, immunohistochemistry, and immunofluorescence. 3D X-ray histology can be readily applied to a plethora of archival materials, yielding unprecedented opportunities in diagnosis and research of disease.

26 April 2019 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
Christina KaravasiliChristina Karavasili
Christina Karavasili
DADimitrios A. Andreadis
Dimitrios A. Andreadis
OKOrestis L Katsamenis
Orestis L Katsamenis
EPEmmanuel Panteris
Emmanuel Panteris
PAPinelopi Anastasiadou
Pinelopi Anastasiadou
DFDimitrios Fatouros
Dimitrios Fatouros

14 June 2018 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
CGChristos I. Gioumouxouzis
Christos I. Gioumouxouzis
ACAikaterini-Theodora Chatzitaki
Aikaterini-Theodora Chatzitaki
Christina KaravasiliChristina Karavasili
Christina Karavasili
OKOrestis L Katsamenis
Orestis L Katsamenis
Dimitrios TzetzisDimitrios Tzetzis
Dimitrios Tzetzis
DFDimitrios Fatouros
Dimitrios Fatouros